
Sign up to save your podcasts
Or
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
4.2
228228 ratings
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
1,221 Listeners
3,857 Listeners
10,406 Listeners
38,189 Listeners
32,291 Listeners
43,483 Listeners
6,670 Listeners
10,700 Listeners
58 Listeners
2,321 Listeners
29 Listeners
389 Listeners
6,751 Listeners
3 Listeners
0 Listeners
5 Listeners
15,335 Listeners
103 Listeners
1,471 Listeners
459 Listeners